Connection

Andrew Pollard to Typhoid-Paratyphoid Vaccines

Back to Details
This is a "connection" page, showing publications Andrew Pollard has written about Typhoid-Paratyphoid Vaccines.
Andrew Pollard
Connection Strength
3.403
Typhoid-Paratyphoid Vaccines
  1. Generating the Evidence for Typhoid Vaccine Introduction: Considerations for Global Disease Burden Estimates and Vaccine Testing Through Human Challenge. Clin Infect Dis. 2019 10 15; 69(Suppl 5):S402-S407.
    View in: PubMed
    Score: 0.806
  2. Seroefficacy of Vi Polysaccharide-Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV). Clin Infect Dis. 2018 06 18; 67(1):18-24.
    View in: PubMed
    Score: 0.736
  3. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy. PLoS Negl Trop Dis. 2018 04; 12(4):e0006408.
    View in: PubMed
    Score: 0.728
  4. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. Lancet. 2017 Dec 02; 390(10111):2472-2480.
    View in: PubMed
    Score: 0.700
  5. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study. Lancet Infect Dis. 2019 07; 19(7):728-739.
    View in: PubMed
    Score: 0.196
  6. Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG. Biologicals. 2018 Nov; 56:29-38.
    View in: PubMed
    Score: 0.187
  7. Typhoid-From Past to Future. Clin Infect Dis. 2019 10 15; 69(Suppl 5):S375-S376.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.